title: Deferasirox induced liver injury in haemochromatosis.
abstract: Durg-induced liver injury is a common side-effect of many medicines. It is particularly problem when the original condition under treatment is already causing liver damage. This report describes the hepatotoxicity induced by Deferasirox in a patient with haemochromatosis with a discussion of possible pathogenetic mechanism.
authors.affiliation: Department of Gastroenterology and Hepatology, University of Louisville, KY 40202, USA. drnaeem12@gmail.com
authors.forename: Naeem
authors.initials: N
authors.lastname: Aslam
authors.forename: Parveen
authors.initials: P
authors.lastname: Mettu
authors.forename: Luis S
authors.initials: LS
authors.lastname: Marsano-Obando
authors.forename: Anthony
authors.initials: A
authors.lastname: Martin
mesh_terms: D001565:Benzoates / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D000077588:Deferasirox; D005260:Female; D006432:Hemochromatosis / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007502:Iron Chelating Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D014230:Triazoles / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D001565:Benzoates; D007502:Iron Chelating Agents; D014230:Triazoles; D000077588:Deferasirox